VS
stockvs
Go to ScreenerHub
MRK

MRK vs PFE

PFE

In the past 12 months, MRK returned +55% while PFE gained 12%.

MRK
MRK

Merck & Co., Inc.

$118.72
7.0%(1M)
Market Cap293.2B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio32.85
ROE17.9%
P/B Ratio6.40
Dividend Yield2.8%
PFE
PFE

Pfizer Inc.

$26.17
-0.3%(1M)
Market Cap149.2B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio19.88
ROE8.4%
P/B Ratio1.65
Dividend Yield6.6%
Performance Comparison

Historical returns across multiple timeframes

MRK leads 8/8
MRK

MRK

Merck & Co., Inc.

+55.4%

1Y Return

PFE

PFE

Pfizer Inc.

+11.6%

1Y Return

MRK
MRK
PFE
PFE

Short Term

1M-6M

MRK
+5.4%

Medium Term

YTD-1Y

MRK
+34.1%

Long Term

3Y-10Y

MRK
+65.2%

Valuation

Compare price multiples and valuation ratios

MRK: 0PFE: 5
MetricMRKPFEWinner
P/E Ratio

Price to earnings ratio

32.8519.88PFE
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

4.472.36PFE
P/B Ratio

Price to book ratio

6.401.65PFE
P/FCF Ratio

Price to free cash flow ratio

20.7715.73PFE
EV/EBITDA

Enterprise value to EBITDA

14.8512.51PFE
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

MRK: 6PFE: 0
MetricMRKPFEWinner
Gross Margin

Gross profit margin

75.9%69.3%MRK
Operating Margin

Operating profit margin

27.6%23.4%MRK
Net Margin

Net profit margin

13.6%11.8%MRK
ROE

Return on equity

17.9%8.4%MRK
ROA

Return on assets

6.9%3.6%MRK
ROIC

Return on invested capital

13.3%8.0%MRK

Growth

Compare revenue and earnings growth rates

MRK: 6PFE: 0
MetricMRKPFEWinner
Revenue Growth (YoY)

Year-over-year revenue growth

1.2%-1.6%MRK
Revenue Growth (3Y)

3-year revenue CAGR

3.1%-14.6%MRK
Revenue Growth (5Y)

5-year revenue CAGR

9.4%8.5%MRK
EPS Growth (YoY)

Year-over-year EPS growth

8.0%-3.5%MRK
EPS Growth (3Y)

3-year EPS CAGR

8.4%-37.1%MRK
EPS Growth (5Y)

5-year EPS CAGR

21.2%-3.5%MRK

Balance Sheet & Risk

Compare financial stability and debt levels

MRK: 4PFE: 1
MetricMRKPFEWinner
Debt/Equity

Debt to equity ratio

1.070.72PFE
Current Ratio

Current assets to current liabilities

1.301.25MRK
Quick Ratio

Quick assets to current liabilities

1.060.94MRK
Interest Coverage

EBIT to interest expense

17.355.53MRK
Beta

Stock volatility vs market

0.200.31MRK
Summary
MRK wins 3-1

Valuation

PFE

Profitability

MRK

Growth

MRK

Balance Sheet

MRK

PFE is more attractively valued. MRK shows stronger profitability. MRK demonstrates better growth. MRK has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into MRK and PFE with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/MRK/vs/PFE" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare MRK vs PFE on stockvs.app
</a>